Case Studies & Proof of ROI

Estimate the financial impact of RBQM adoption and uncover opportunities for operational efficiency.

Case Studies & Proof of ROI

Estimate the financial impact of RBQM adoption and uncover opportunities for operational efficiency.

Cyntegrity logo – Risk-Based Quality Management Solutions

Clinical operations efficiency is not just about speed—it’s about strategic optimization that saves time, money, and resources without compromising quality. The ClinOps Cost Savings Calculator helps sponsors and CROs assess the economic value of implementing risk-based quality management (RBQM), centralized monitoring, and predictive analytics. This collection of resources explains how to interpret your results, apply cost-saving insights, and build a data-backed business case for digital transformation in clinical research.

Explore Cost Optimization
Strategies and Insights

ICH E6(R3) Sponsor Responsibilities: What’s New and What It Means for You...

Understand sponsor responsibilities under ICH E6(R3) and how to meet modern GCP expectations using risk-based, data-driven oversight....

5 Key Questions to Ask When Evaluating RBQM Platforms (ICH E6(R3)-Ready)...

Learn the 5 essential evaluation questions when comparing RBQM systems. Ensure transparency, traceability, collaboration, and E6(R3) compliance....

Latest from the Knowledge Center

Stay updated on evolving industry trends and data-driven
RBQM practices through our most recent articles.

Leverage the Calculator 
and Supporting Materials

ClinOps Cost Savings Calculator

Estimate the financial impact of RBQM adoption and uncover opportunities for operational efficiency.

ClinOps Cost Savings Calculator

Estimate the financial impact of RBQM adoption and uncover opportunities for operational efficiency.

ClinOps Cost Savings Calculator

Estimate the financial impact of RBQM adoption and uncover opportunities for operational efficiency.

Service Level Availability – SLA

Service Level Availability or “SLA” means the targeted availability levels measured in the Production environment, as specified in the SaaS Listing which may vary according to each SaaS Offering and its component capabilities....

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use....

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What clinical trial teams must understand to stay inspection-ready....

Global Uncertainty and Clinical Research: Why a Risk-Based Perspective Matters

Global risks in clinical trials are increasing as geopolitical instability, supply chain disruptions, and regulatory changes affect research worldwide. Learn why RBQM is essential for proactive oversight....

AI Use in Clinical Trials Is Increasing.
So Are Regulatory Expectations.

Regulators expect controlled, documented, and reviewable AI use. Prepare your teams to apply AI within GCP and computerized system requirements.